Analyst Rating
based on 10 analysts
80.00%
Buy
10.00%
Hold
10.00%
Sell
Based on 10 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹432.1
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Share analysis
Healthcare Global Enterprises Ltd price forecast by 10 analysts
Upside of6.98%
High
₹500
Target
₹432.10
Low
₹370
Healthcare Global Enterprises Ltd target price ₹432.1, a slight upside of 6.98% compared to current price of ₹403.9. According to 10 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Healthcare Global Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2026:48.38%
Forecast
Actual
Including amortisation and stock based compensations
Healthcare Global Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2026:277.25%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹402₹412.152 Week's Low
52 Week's High
₹314₹412.1
| Returns % | |
| 1 Month Return | + 10.37 % |
| 3 Month Return | + 10.64 % |
| 1 Year Return | + 9.15 % |
| Market Stats | |
| Previous Close | ₹409.90 |
| Open | ₹409.55 |
| Volume | 2.00L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹5,711.87Cr |
Key Statistics
| P/E Ratio | 106.85 |
| PEG Ratio | 68.49 |
| Market Cap | ₹5,711.87 Cr |
| P/B Ratio | 3.19 |
| EPS | 2.97 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 3.07 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹5,711.87 Cr | 60.9% | 0.63 | ₹41 Cr | ₹1,907 Cr | |
| NA | ₹252.25 Cr | 4.41% | 0.53 | ₹10 Cr | ₹48 Cr | |
| BUY | ₹14,566.69 Cr | 3.29% | 0.54 | ₹336 Cr | ₹2,589 Cr | |
| NA | ₹221.10 Cr | 21.97% | 0.64 | ₹4 Cr | ₹39 Cr | |
| NA | ₹62.52 Cr | -12.81% | 0.50 | NA | ₹45 Cr |
Mutual Fund Holdings
Company Information
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Share Price: ₹403.90 per share as on 06 Sep, 2024 04:01 PM
Market Capitalisation: ₹5,711.87Cr as of today
Revenue: ₹524.69Cr as on June 2024 (Q2 24)
Net Profit: ₹13.63Cr as on June 2024 (Q2 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Healthcare Global Enterprises Ltd
Bain Capital Leads Bid for HealthCare Global Enterprises - 13 Aug, 2024
Bain Capital is reportedly the frontrunner to acquire a controlling stake in HealthCare Global Enterprises Ltd from CVC Capital Partners. The deal could involve a premium over the current market price, with CVC's stake valued at approximately $356 million. Ongoing negotiations may still face challenges, and other bidders could emerge.
HCG Reports Strong Q1 Growth in Profit and Revenue - 09 Aug, 2024
Healthcare Global Enterprises Ltd (HCG) reported a 58.7% increase in consolidated net profit to Rs 12.08 crore for Q1 FY25, with revenue rising to Rs 525.6 crore. The company expanded its portfolio through the acquisition of Mahatma Gandhi Cancer Hospital and Research Institute, contributing to significant growth across various regions.
Healthcare Global Enterprises Faces Challenges Amid Expansion Plans - 15 Jul, 2024
Healthcare Global Enterprises plans to add 475 beds and two cancer care centers, but faces challenges in improving occupancy, ARPOB, and cost rationalization. Competition in oncology and delays in operational turnaround of new centers also pose risks.
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 6.49% to 8.73% in Jun 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 13.46% to 13.90% in Jun 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, HCG stock has moved up by 4.4%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 475.94 Cr → 534.39 Cr (in ₹), with an average increase of 5.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 137.2% return, outperforming this stock by 69.0%
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 62.7% return, outperforming this stock by 53.5%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 21.26 Cr → 12.08 Cr (in ₹), with an average decrease of 43.2% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 6.74% to 3.95% in Jun 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.28% to 71.25% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.25% | ||
| Foreign Institutions | 3.95% | ||
| Mutual Funds | 8.73% | 34.59 | |
| Retail Investors | 13.9% | 3.33 | |
| Others | 2.16% | 6.33 |
Key Indicators
Healthcare Global Enterprises Ltd Valuation
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (95.94x)
September 6, 2024
Today (106.85x)
September 6, 2024
Highest (201.31x)
July 2, 2018
Earnings and Dividends
Healthcare Global Enterprises Ltd Earnings Results
Healthcare Global Enterprises Ltd’s net profit jumped 58.74% since last year same period to ₹12.08Cr in the Q1 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated -43.18% fall in its net profits since last 3-months.
Read More about Earnings Results
Technicals Summary
Bearish
Neutral
Bullish
Healthcare Global Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Healthcare Global Enterprises Ltd shares.
Healthcare Global Enterprises Ltd (HCG) share price today is ₹403.9
Healthcare Global Enterprises Ltd is listed on NSE
Healthcare Global Enterprises Ltd is listed on BSE
- Today’s highest price of Healthcare Global Enterprises Ltd is ₹412.1.
- Today’s lowest price of Healthcare Global Enterprises Ltd is ₹402.
PE Ratio of Healthcare Global Enterprises Ltd is 106.85
PE ratio = Healthcare Global Enterprises Ltd Market price per share / Healthcare Global Enterprises Ltd Earnings per share
Today’s traded volume of Healthcare Global Enterprises Ltd(HCG) is 2.00L.
Today’s market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹5711.87Cr.
| Healthcare Global Enterprises Ltd(HCG | Price |
|---|---|
52 Week High | ₹412.1 |
52 Week Low | ₹314 |
Healthcare Global Enterprises Ltd(HCG) share price is ₹403.9. It is down -1.99% from its 52 Week High price of ₹412.1
Healthcare Global Enterprises Ltd(HCG) share price is ₹403.9. It is up 28.63% from its 52 Week Low price of ₹314
| Healthcare Global Enterprises Ltd(HCG | Returns |
|---|---|
1 Day Returns | -6% |
1 Month Returns | 10.37% |
3 Month Returns | 10.64% |
1 Year Returns | 9.15% |